Living in Limbo: Managing Risk, Care, and Clarity with a Precursor Condition

Name: Living in Limbo: Managing Risk, Care, and Clarity with a Precursor Condition
Start: 2025-09-02T14:00:00-04:00
End: 2025-09-02T15:00:00-04:00

Living in Limbo: Managing Risk, Care, and Clarity with a Precursor Condition

Webinar

Sep 02, 2025 / 02:00PM - 03:00PM EDT

videocam

Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Being diagnosed with a blood cancer precursor like MGUS, SMM, CHIP, CCUS, MDS/MPNs, can feel like living in medical limbo. In this session, Dr. Tremblay from Mount Sianai will address key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials. Whether you’re newly diagnosed or monitoring your condition over time, this webinar will help you better understand your diagnosis and confidently navigate what comes next.

Schedule & Agenda

2:00 PM

Introduction

Mary Arnett

Mary introduces the agenda and our featured speaker Dr. Douglas Tremblay

2:00 PM

Introduction

Mary Arnett

Mary introduces the agenda and our featured speaker Dr. Douglas Tremblay

2:05 PM

Presentation

Douglas Tremblay, MD

Dr. Douglas Tremblay talks about key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials

2:05 PM

Presentation

Douglas Tremblay, MD

Dr. Douglas Tremblay talks about key concerns like the risk of progression, treatment decisions, how to partner with your care team, and the role of clinical trials

2:35 PM

Questions and Answers

Audience

Come with your questions and we will answer them!

2:35 PM

Questions and Answers

Audience

Come with your questions and we will answer them!

Speakers & Moderators

Mary Arnett

Salt Lake City, UT

Mary joined HealthTree in 2022. She is now the AML & MDS Patient Engagement Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Read Bio

Douglas Tremblay, MD

New York, New York

Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Dr. Tremblay specializes in hematologic malignancies including acute myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.

Read Bio

Join the Conversation

This event is part of the Watch and Wait group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.